Lovastatin and Vitreous floaters - a phase IV clinical study of FDA data

Summary:

Vitreous floaters is reported as a side effect among people who take Lovastatin (lovastatin), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Lucentis, and have Procedural pain.

The phase IV clinical study analyzes which people have Vitreous floaters when taking Lovastatin. It is created by eHealthMe based on reports of 31,864 people who have side effects when taking Lovastatin from the FDA, and is updated regularly.

What is Lovastatin?

Lovastatin has active ingredients of lovastatin. It is often used in high blood cholesterol. eHealthMe is studying from 33,048 Lovastatin users. Check the latest studies of Lovastatin.

What is Vitreous floaters?

Vitreous floaters (spots before the eyes) is found to be associated with 834 drugs and 838 conditions by eHealthMe. Check the latest studies of Vitreous floaters.

On Aug, 07, 2026

31,864 people reported to have side effects when taking Lovastatin.
Among them, 54 people (0.17%) have Vitreous floaters.

Could Lovastatin cause Vitreous floaters?

Among these 54 people:

How long have people been on Lovastatin when they have Vitreous floaters? *

What is the gender of people who have Vitreous floaters when taking Lovastatin? *

female: 32.69 %
male: 67.31 %

What is the age of people who have Vitreous floaters when taking Lovastatin? *

What are other drugs people take besides Lovastatin? *

What are other side effects people have besides Vitreous floaters? *

Vision Blurred: 34 people, 62.96%
Vitreous Haemorrhage (intraocular (inside the eye) bleeding): 18 people, 33.33%
Visual Acuity Reduced (reduced clearness of vision): 18 people, 33.33%
Blindness: 17 people, 31.48%
Retinal Detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue): 16 people, 29.63%
Cataract (clouding of the lens inside the eye): 16 people, 29.63%
Neuropathy Peripheral (surface nerve damage): 15 people, 27.78%
Drug Ineffective: 14 people, 25.93%
Stress And Anxiety: 13 people, 24.07%
Fall: 13 people, 24.07%

What are the existing conditions these people have? *

Procedural Pain: 9 people, 16.67%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 8 people, 14.81%
Partial Seizures (seizures which affect only a part of the brain at onset): 8 people, 14.81%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 6 people, 11.11%
Pain In Extremity: 5 people, 9.26%
Neuropathy Peripheral (surface nerve damage): 5 people, 9.26%
Age-Related Macular Degeneration: 4 people, 7.41%
Type 2 Diabetes: 4 people, 7.41%
Diabetic Eye Disease: 4 people, 7.41%
Cardiac Disorder: 3 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Lovastatin and have Vitreous floaters?

- Check whether Vitreous floaters is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lovastatin:

Lovastatin (33,048 reports)

Browse all side effects of Lovastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vitreous floaters:

Vitreous floaters (834 drugs)

Browse all the conditions that are associated with Vitreous floaters:

Vitreous floaters (838 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lovastatin (the active ingredients of Lovastatin) and Lovastatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.